 REDWOOD CITY, Calif., Nov. 04, 2022 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx, a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming investor conferences in New York. 